Stifel 2024 Healthcare Conference
Logotype for 908 Devices Inc

908 Devices (MASS) Stifel 2024 Healthcare Conference summary

Event summary combining transcript, slides, and related documents.

Logotype for 908 Devices Inc

Stifel 2024 Healthcare Conference summary

13 Jan, 2026

Business overview and growth drivers

  • Focus on point-of-need chemical detection, expanding lab-grade tools beyond central labs, with a strong forensic franchise making up about 75% of revenues and 2,700 handheld devices deployed.

  • Bioprocessing/biopharma desktop devices have faced macro headwinds but are supported by five articulated growth drivers and cost structure improvements, including RedWave Technology acquisition.

  • Handhelds have grown at a 27% CAGR from 2018–2023, with recent years above 14% CAGR, despite government budget delays causing sales lumpiness.

  • Portfolio expansion from one to four handheld products and increased international and state/local sales help balance revenue volatility.

  • Reference customers, such as the U.S. Army, have aided in expanding enterprise accounts.

RedWave acquisition and product synergies

  • RedWave brings FTIR technology, complementing mass spec handhelds, expanding analyte detection to 22,000 in bulk and 5,000 gases.

  • Sales and applications teams are well-positioned to integrate RedWave products, leveraging existing training and commercial infrastructure.

  • Identified $7.5 million in cost and revenue synergies, with RedWave's state/local presence and new federal/international opportunities.

  • Cross-selling is already occurring, with bundled deals and broader customer engagement.

  • RedWave's trajectory is expected to match historical handheld growth rates.

Market expansion and untapped applications

  • FTIR and mass spec technologies are applicable to diagnostics, food, air, water, forensics, and bioprocessing.

  • XplorIR, a RedWave product, enables detection of 5,000 gases, broadening applications to environmental and hazmat markets.

  • Year-to-date shipments of XplorIR have doubled compared to the previous year.

  • International enterprise accounts are growing, with the largest APAC order shipped in October and expansion in the Middle East and Europe.

  • Diversification across products and markets helps mitigate reliance on large enterprise accounts.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more